Diversity in Clinical Pharmacology: A Call to Action.

Karen Brown, Shravani Etrouth, Priya Jayachandran, Jason Moore, Akinyemi Oni-Orisan, Lakshmi Vasist, Songmao Zheng, Zhu Zhou, Mark Dresser
Author Information
  1. Karen Brown: University of Montana, Missoula, Montana, USA. ORCID
  2. Shravani Etrouth: Jawaharlal Nehru Technological University, Hyderabad, India. ORCID
  3. Priya Jayachandran: Pfizer Inc, Cambridge, Massachusetts, USA. ORCID
  4. Jason Moore: Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  5. Akinyemi Oni-Orisan: University of California San Francisco, San Francisco, California, USA. ORCID
  6. Lakshmi Vasist: GlaxoSmithKline, Chapel Hill, North Carolina, USA.
  7. Songmao Zheng: Adagene Inc, San Diego, California, USA.
  8. Zhu Zhou: York College, The City University of New York, Jamaica, New York, USA.
  9. Mark Dresser: University of California San Francisco, San Francisco, California, USA.

Abstract

Prioritization of diversity, equity, and inclusion in all facets of our work is long overdue for the clinical pharmacology community. Increasing diversity in clinical research will deepen our understanding of nuanced patient populations and help improve all patient outcomes. Fostering an inclusive and diverse workforce will lead to broader perspectives that can better inform critical decisions and create work environments where everyone can thrive. In this call to action, we invite you to join us.

References

  1. J Clin Oncol. 2021 Dec 20;39(36):4004-4008 [PMID: 34672688]
  2. Science. 2020 Feb 14;367(6479):749-750 [PMID: 32054753]
  3. Pharmacol Res. 2022 Feb;176:106087 [PMID: 35033648]
  4. Circulation. 2021 Jun 15;143(24):2409-2411 [PMID: 34125567]
  5. Nat Med. 2022 Feb;28(2):243-250 [PMID: 35145307]

Grants

  1. K01 HL143109/NHLBI NIH HHS
  2. R16 GM146679/NIGMS NIH HHS

MeSH Term

Humans
Pharmacology, Clinical
Cultural Diversity
Workforce

Word Cloud

Created with Highcharts 10.0.0diversityworkclinicalwillpatientcanPrioritizationequityinclusionfacetslongoverduepharmacologycommunityIncreasingresearchdeepenunderstandingnuancedpopulationshelpimproveoutcomesFosteringinclusivediverseworkforceleadbroaderperspectivesbetterinformcriticaldecisionscreateenvironmentseveryonethrivecallactioninvitejoinusDiversityClinicalPharmacology:CallAction

Similar Articles

Cited By